| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.48▲ | 5.44▲ | 5.45▲ | 5.32▲ | 5.17▲ |
| MA10 | 5.46▲ | 5.44▲ | 5.41▲ | 5.31▲ | 5.20▲ |
| MA20 | 5.44▲ | 5.40▲ | 5.35▲ | 5.12▲ | 5.39▲ |
| MA50 | 5.44▲ | 5.31▲ | 5.29▲ | 5.23▲ | 5.40▲ |
| MA100 | 5.40▲ | 5.29▲ | 5.17▲ | 5.40▲ | 6.10▼ |
| MA200 | 5.33▲ | 5.14▲ | 5.08▲ | 5.27▲ | 6.95▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.003▲ | 0.011▲ | 0.044▲ | -0.003▼ |
| RSI | 68.723▲ | 69.415▲ | 68.035▲ | 60.758▲ | 52.329▲ |
| STOCH | 94.583▲ | 73.976 | 85.313▲ | 75.320 | 32.180 |
| WILL %R | -12.500▲ | -5.263▲ | -4.878▲ | -2.353▲ | -42.361 |
| CCI | 83.146 | 124.444▲ | 150.498▲ | 104.852▲ | 18.707 |
|
Sunday, December 03, 2023 01:20 AM
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 30, 2023, NexImmune, Inc. (the “Company”) received a notice from the Listing ...
|
|
Tuesday, November 28, 2023 06:25 PM
Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today ...
|
|
Monday, November 27, 2023 05:59 PM
For 50 years, Nasdaq has been a leader in the exchange space through our technology innovations. We built our IPO process in partnership with the investment banking community, ensuring that they ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/12/23 | 5.35 | 5.49 | 5.28 | 5.47 | 517,199 |
| 30/11/23 | 5.35 | 5.41 | 5.265 | 5.38 | 562,501 |
| 29/11/23 | 5.16 | 5.35 | 5.155 | 5.33 | 457,829 |
| 28/11/23 | 5.27 | 5.27 | 5.14 | 5.14 | 369,976 |
| 27/11/23 | 5.21 | 5.31 | 5.17 | 5.28 | 525,207 |
| 24/11/23 | 5.29 | 5.31 | 5.19 | 5.20 | 203,353 |
| 22/11/23 | 5.34 | 5.37 | 5.24 | 5.27 | 227,534 |
| 21/11/23 | 5.33 | 5.355 | 5.26 | 5.33 | 396,810 |
| 20/11/23 | 5.33 | 5.40 | 5.245 | 5.36 | 463,175 |
| 17/11/23 | 5.26 | 5.3675 | 5.20 | 5.33 | 556,410 |
|
|
||||
|
|
||||
|
|